Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 5086 AL 5100

Patents on potential drugs to treat Alzheimer's disease: special emphasis on small peptides

Sundaram P, Nambiar AK, Sundaram RK.

Recent Pat CNS Drug Discov. 2014;9(2):71-5. doi: 10.2174/1574889809666140919123006.

Factors Associated With Preferences for Institutionalized Care in Elderly Persons: Comparing Hypothetical Conditions of Permanent Disability and Alzheimer's Disease

Werner P, Segel-Karpas D.

J Appl Gerontol. 2016 Apr;35(4):444-64. doi: 10.1177/0733464814546041. Epub 2014 Sep 22.

[Alzheimer's disease: New therapeutic strategies]

Villegas S.

Med Clin (Barc). 2015 Jul 20;145(2):76-83. doi: 10.1016/j.medcli.2014.05.023. Epub 2014 Sep 20.

The neurosurgical treatment of Alzheimer's disease: a review

Laxton AW, Stone S, Lozano AM.

Stereotact Funct Neurosurg. 2014;92(5):269-81. doi: 10.1159/000364914. Epub 2014 Sep 18.

Targeting brain α7 nicotinic acetylcholine receptors in Alzheimer's disease: rationale and current status

Vallés AS, Borroni MV, Barrantes FJ.

CNS Drugs. 2014 Nov;28(11):975-87. doi: 10.1007/s40263-014-0201-3.

Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy

Latta CH, Brothers HM, Wilcock DM.

Neuroscience. 2015 Aug 27;302:103-11. doi: 10.1016/j.neuroscience.2014.09.061. Epub 2014 Oct 5.

Alzheimer's disease and epigenetic diet

Sezgin Z, Dincer Y.

Neurochem Int. 2014 Dec;78:105-16. doi: 10.1016/j.neuint.2014.09.012. Epub 2014 Oct 5.

Advances in recent patent and clinical trial drug development for Alzheimer's disease

Liu H, Wang L, Su W, Xie XQ.

Pharm Pat Anal. 2014 Jul;3(4):429-47. doi: 10.4155/ppa.14.22.

Learning by failing: ideas and concepts to tackle γ-secretases in Alzheimer's disease and beyond

De Strooper B, Chávez Gutiérrez L.

Annu Rev Pharmacol Toxicol. 2015;55:419-37. doi: 10.1146/annurev-pharmtox-010814-124309. Epub 2014 Oct 1.

NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease

Lawlor B, Kennelly S, O'Dwyer S, Cregg F, Walsh C, Coen R, Kenny RA, Howard R, Murphy C, Adams J, Daly L, Segurado R, Gaynor S, Crawford F, Mullan M, Lucca U, Banzi R, Pasquier F, Breuilh L, Riepe M, Kalman J, Wallin A, Borjesson A, Molloy W, Tsolaki M, Olde Rikkert M.

BMJ Open. 2014 Oct 9;4(10):e006364. doi: 10.1136/bmjopen-2014-006364.

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease

Newport MT, VanItallie TB, Kashiwaya Y, King MT, Veech RL.

Alzheimers Dement. 2015 Jan;11(1):99-103. doi: 10.1016/j.jalz.2014.01.006. Epub 2014 Oct 7.

Dietary polyphenols for treatment of Alzheimer's disease--future research and development

Malar DS, Devi KP.

Curr Pharm Biotechnol. 2014;15(4):330-42. doi: 10.2174/1389201015666140813122703.

Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment

Pasinetti GM, Wang J, Ho L, Zhao W, Dubner L.

Biochim Biophys Acta. 2015 Jun;1852(6):1202-8. doi: 10.1016/j.bbadis.2014.10.006. Epub 2014 Oct 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias